Greenlight Capital - TALIS BIOMEDICAL CORP ownership

TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 46 filers reported holding TALIS BIOMEDICAL CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Greenlight Capital ownership history of TALIS BIOMEDICAL CORP
ValueSharesWeighting
Q2 2023$1,073,176
-2.0%
2,235,7830.0%0.05%
-16.7%
Q1 2023$1,095,534
+9.9%
2,235,7830.0%0.06%
-13.0%
Q4 2022$996,488
-34.6%
2,235,7830.0%0.07%
-36.1%
Q3 2022$1,524,000
-16.1%
2,235,7830.0%0.11%
-23.4%
Q2 2022$1,816,000
-42.4%
2,235,7830.0%0.14%
-29.5%
Q1 2022$3,152,000
-49.9%
2,235,783
+42.5%
0.20%
-44.4%
Q4 2021$6,293,0001,569,3000.36%
Other shareholders

There were no reported owners of TALIS BIOMEDICAL CORP in Q1 2022.

NameSharesValueWeighting ↓
View complete list of TALIS BIOMEDICAL CORP shareholders